Tag: genomics
-
Synthetic Biology Company Raises $105M in New Funds
A company developing cellular and genetic therapies for cancer designed like electronic circuits is raising $105 million in its second venture round.
-
FDA Issues Precision Genomic Drug Guidance
The U.S. Food and Drug Administration issued draft administrative and procedural guidelines for genetic disorders treated with precise gene therapies.
-
Trial OKed for Rare Disease Gene Therapy
A start-up biotech company says it received clearance from the Food and Drug Administration to begin a clinical trial of its gene therapy for Krabbe disease.
-
Device-Aided Covid-19 Vaccine Invokes Immune Response
Results from an early clinical trial show a Covid-19 vaccine using an electronic device to boost uptake in cells is safe and generates an immune-system response.
-
Gates Funding Home-Based Crispr Covid-19 Diagnostic
A medical device developer is receiving a Gates Foundation grant for a simple test to detect Covid-19 infections, done completely at home.
-
AbbVie Acquires Coronavirus Antibody Therapy
Drug maker AbbVie is licensing a synthetic antibody to treat Covid-19 and SARS coronaviruses that the company began funding in June.
-
Bayer Gains Lung Cancer Therapy in $670M Deal
Global drug maker Bayer AG is licensing an engineered T-cell therapy to treat mesothelioma and other solid tumor cancers from biotech Atara Biotherapeutics.
-
Small Biz Grant Funds AI Repro Health Technology
A company developing health metrics with artificial intelligence received a grant to better understand polycystic ovary syndrome, an endocrine disorder affecting women.
-
Inexpensive Chip Detects Covid-19, Other Pathogens
A small silicon lab-on-a-chip device costing about $0.35 to make is shown in lab tests to quickly detect SARS-CoV-2 viruses and infectious bacteria.
-
Simpler Method Devised to Validate Covid-19 Tests
An engineering lab created simple and stable control probes to validate widely used diagnostic tests for SARS-Cov-2 viruses responsible for Covid-19.